We show that JADE2 is predominantly downregulated in NSCLC at the mRNA but not at protein level, and that expression of JADE2 has prognostic value and is associated with a better 5-year overall survival (OS). The gene discussed is JADE2; the disease is non-small cell lung carcinoma.